Medifocus (PINK:MDFZF) said it brought in $3.5 million in a private offering of convertible debt, a raise tied to company’s August non-brokered private placement of $6 million.
Medifocus
Second Sight eyes $10M funding round | Wall Street Beat
Second Sight Medical is hoping to raise $10.5 million, according to a regulatory filing, as it brings its "bionic eye" Argus II retinal implant to the U.S. market.
The device, comprised of an eyeglass-mounted camera and an electrical stimulator implanted in the eye, works by converting video images captured by a miniature camera housed in the patient’s glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes on the surface of the retina.
Boston Scientific sells Prolieve device back to Medifocus for $5M
Updated June 28, 2012, at 12:45 p.m. with comments from Medifocus.
Medical device titan Boston Scientific (NYSE:BSX) sold the Prolieve business back to Medifocus (PINK:MDFZF) in a deal valued at $5 million.
Report: J&J set for EU OK on Synthes buyout | Wall Street Beat
European Union regulators are poised to give the OK to Johnson & Johnson‘s (NYSE:JNJ) $21.3 billion acquisition of Swiss orthopedic giant Synthes, according to Reuters.